Your browser doesn't support javascript.
loading
When Would Immunologists Consider a Nanomaterial to be Safe? Recommendations for Planning Studies on Nanosafety.
Himly, Martin; Geppert, Mark; Hofer, Sabine; Hofstätter, Norbert; Horejs-Höck, Jutta; Duschl, Albert.
Afiliação
  • Himly M; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
  • Geppert M; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
  • Hofer S; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
  • Hofstätter N; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
  • Horejs-Höck J; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
  • Duschl A; Department for Biosciences & Allergy Cancer BioNano Research Centre, University of Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria.
Small ; 16(21): e1907483, 2020 05.
Article em En | MEDLINE | ID: mdl-32239645
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanoestruturas / Imunidade Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanoestruturas / Imunidade Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article